Skip to main content
Accueil
  • fr
  • en

Main navigation

  • Company
    • Company profile
    • Management
    • Our history
    • Great Place to Work
  • Science
    • Scientific approach
    • Innate Immunity & NK cells
    • Antibody formats
    • Publications
  • Products
    • Pipeline overview
    • Clinical trials
    • ------------------
    • Lacutamab
    • Monalizumab
    • Avdoralimab
    • IPH5201
    • IPH5301
    • IPH6101
    • IPH62
    • ------------------
    • LUMOXITI
  • Partnering
  • Investors
    • Overview
    • News & Events
    • Financial and Regulatory Information
    • General Shareholders Meeting
    • Share Information
    • Investor Kit
    • Corporate Governance
  • Media
    • Media hub
    • All press releases
    • Media center
  • Careers

Lacutamab, a first-in-class antibody for cutaneous t-cell lymphoma


More about our lead asset

Harnessing the power of NK cells to develop therapeutic antibodies


Discover our cutting-edge science

Collaborating with a strong network to advance our pipeline


Discover our partnering opportunities

Previous Next

About Innate Pharma

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.

See company profile

Latest news

Innate Pharma reports Full Year 2020 financial results and business update

March 18, 2021

Innate Pharma announces conference call and webcast for Full Year 2020 financial results

March 16, 2021

Number of shares and voting rights of Innate Pharma as of February 1, 2021

February 24, 2021
See all press releases

Footer

  • Contact
  • Location
  • Legal Info
  • Terms of use
  • Privacy Notice
  • Cookies notice

Follow us

   

Stay in touch

 Subscribe to our newsletter

 Contact us
 

Location

117, Avenue de Luminy - BP 30191
13 009 Marseille FRANCE

 +33 (0)4 30 30 30 30

 Innate Pharma, Inc.
2273 Research Boulevard, Suite 350
Rockville, MD 20850, USA

Innate Pharma